These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22494236)

  • 1. Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
    Peglow S; Buchner J; Briscoe G
    Am J Addict; 2012; 21(3):287-8. PubMed ID: 22494236
    [No Abstract]   [Full Text] [Related]  

  • 2. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Could spice drugs induce psychosis with abnormal movements similar to catatonia?
    Haro G; Ripoll C; Ibáñez M; Orengo T; Liaño VM; Meneu E; Hernández F; Traver F
    Psychiatry; 2014; 77(2):206-8. PubMed ID: 24865202
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
    Mörkl S; Blesl C; Wurm WE; Tmava A
    Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoids as drugs of abuse.
    Ashton JC
    Curr Drug Abuse Rev; 2012 Jun; 5(2):158-68. PubMed ID: 22530798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
    Fattore L
    Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic and synthetic cannabinoid use in adolescents.
    Bhatty S; Wu W
    Pediatr Ann; 2013 Jan; 42(1):31-5. PubMed ID: 23316832
    [No Abstract]   [Full Text] [Related]  

  • 10. "Spice" girls: synthetic cannabinoid intoxication.
    Schneir AB; Cullen J; Ly BT
    J Emerg Med; 2011 Mar; 40(3):296-9. PubMed ID: 21167669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
    Tung CK; Chiang TP; Lam M
    East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic stroke following use of the synthetic marijuana "spice".
    Rose DZ; Guerrero WR; Mokin MV; Gooch CL; Bozeman AC; Pearson JM; Burgin WS
    Neurology; 2015 Sep; 85(13):1177-9. PubMed ID: 26320200
    [No Abstract]   [Full Text] [Related]  

  • 14. Adolescence and drug abuse: biomedical consequences.
    Cohen S
    NIDA Res Monogr; 1980; 38():104-12. PubMed ID: 6121291
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychiatric sequelae of Spice, K2, and synthetic cannabinoid receptor agonists.
    Benford DM; Caplan JP
    Psychosomatics; 2011; 52(3):295. PubMed ID: 21565605
    [No Abstract]   [Full Text] [Related]  

  • 16. A case of ischemic stroke after bonzai: syntetic cannabinoid from Turkey.
    Degirmenci Y; Kececi H; Olmez N
    Neurol Sci; 2016 Feb; 37(2):299-300. PubMed ID: 26466589
    [No Abstract]   [Full Text] [Related]  

  • 17. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Products containing synthetic cannabinoids and psychosis.
    Brakoulias V
    Aust N Z J Psychiatry; 2012 Mar; 46(3):281-2. PubMed ID: 22391292
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic Cannabinoid Receptor Agonists: a heterogeneous class of novel psychoactive substance with emerging risk of psychosis.
    Whiting D
    Evid Based Ment Health; 2015 Nov; 18(4):110. PubMed ID: 26363038
    [No Abstract]   [Full Text] [Related]  

  • 20. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
    Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
    Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.